Lixte Biotechnology Holdings's total assets for Q were $1.70M, a decrease of -36.43% from the previous quarter. LIXT total liabilities were $328.96K for the fiscal quarter, a -21.95% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.